Valneva SE
XMUN:AYJ
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
V
|
Valneva SE
XMUN:AYJ
|
FR |
|
Huuuge Inc
F:7EI
|
US |
|
P
|
PPL Corp
XMUN:PP9
|
US |
Intrinsic Value
The intrinsic value of 
Valneva SE (AYJ) under the Base Case is 1.343 EUR per share.
Compared with the current market price of 2.393 EUR, the stock appears
Overvalued by 44% .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Valneva Does
Valneva is a vaccine company. It develops, makes, and sells vaccines that help prevent infectious diseases, with a focus on travel and other niche areas where public health agencies and doctors need specific protection rather than broad everyday medicines. Its best-known products include vaccines for diseases such as Japanese encephalitis, cholera, and other travel-related infections, along with vaccine candidates still in development.
- Headquarters
- France FR
- Employees
- 674
- IPO date
- Jun 28, 2007
Revenue & Expenses Breakdown
Valneva SE
Earnings Waterfall
Valneva SE
The intrinsic value for Valneva SE (AYJ) under the Base Case is 1.343 EUR.
Compared with the current market price of 2.393 EUR, the stock appears Overvalued by 44% .